Comerica Bank’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $275K | Sell |
7,369
-2,068
| -22% | -$100K | ﹤0.01% | 1984 |
|
|
2022
Q3 | $505K | Sell |
9,437
-1,141
| -11% | -$67.9K | ﹤0.01% | 1782 |
|
|
2022
Q2 | $597K | Buy |
10,578
+250
| +2% | +$15.8K | ﹤0.01% | 1765 |
|
|
2022
Q1 | $722K | Sell |
10,328
-7
| -0.1% | -$1.04K | 0.01% | 1720 |
|
|
2021
Q4 | $1.69M | Buy |
10,335
+4,781
| +86% | +$1.04M | 0.01% | 1266 |
|
|
2021
Q3 | $1.36M | Sell |
5,554
-1,082
| -16% | -$260K | 0.01% | 1536 |
|
|
2021
Q2 | $1.3M | Sell |
6,636
-121
| -2% | -$33.5K | 0.01% | 1592 |
|
|
2021
Q1 | $2M | Sell |
6,757
-262
| -4% | -$81.5K | 0.01% | 1349 |
|
|
2020
Q4 | $1.74M | Sell |
7,019
-144
| -2% | -$37.2K | 0.01% | 1385 |
|
|
2020
Q3 | $1.89M | Sell |
7,163
-69
| -1% | -$21.7K | 0.01% | 1163 |
|
|
2020
Q2 | $2.6M | Buy |
7,232
+509
| +8% | +$159K | 0.02% | 905 |
|
|
2020
Q1 | $1.98M | Sell |
6,723
-42
| -0.6% | -$13K | 0.02% | 921 |
|
|
2019
Q4 | $2.06M | Buy |
6,765
+4,488
| +197% | +$1.3M | 0.02% | 1116 |
|
|
2019
Q3 | $563K | Buy |
2,277
+112
| +5% | +$41.1K | ﹤0.01% | 1830 |
|
|
2019
Q2 | $1.04M | Buy |
2,165
+71
| +3% | +$35.6K | 0.01% | 1511 |
|
|
2019
Q1 | $1.13M | Sell |
2,094
-18
| -0.9% | -$10.7K | 0.01% | 1507 |
|
|
2018
Q4 | $1.35M | Sell |
2,112
-815
| -28% | -$492K | 0.01% | 1370 |
|
|
2018
Q3 | $1.73M | Buy |
2,927
+47
| +2% | +$40.1K | 0.01% | 1237 |
|
|
2018
Q2 | $2.09M | Buy |
2,880
+50
| +2% | +$57.7K | 0.01% | 1235 |
|
|
2018
Q1 | $3.83M | Sell |
2,830
-7,947
| -74% | -$10.2M | 0.03% | 809 |
|
|
2017
Q4 | $12.4M | Sell |
10,777
-209
| -2% | -$124K | 0.08% | 254 |
|
|
2017
Q3 | $3.87M | Buy |
10,986
+128
| +1% | +$40K | 0.03% | 765 |
|
|
2017
Q2 | $3.74M | Sell |
10,858
-493
| -4% | -$142K | 0.03% | 760 |
|
|
2017
Q1 | $3.22M | Buy |
11,351
+502
| +5% | +$113K | 0.02% | 875 |
|
|
2016
Q4 | $2.1M | Buy |
10,849
+1,637
| +18% | +$333K | 0.02% | 1159 |
|
|
2016
Q3 | $2.35M | Buy |
9,212
+109
| +1% | +$28.1K | 0.02% | 971 |
|
|
2016
Q2 | $2.37M | Sell |
9,103
-136
| -1% | -$30.4K | 0.02% | 936 |
|
|
2016
Q1 | $2.1M | Buy |
9,239
+217
| +2% | +$41.7K | 0.02% | 990 |
|
|
2015
Q4 | $1.99M | Buy |
9,022
+55
| +0.6% | +$11.3K | 0.02% | 966 |
|
|
2015
Q3 | $1.47M | Sell |
8,967
-8,735
| -49% | -$1.55M | 0.01% | 1218 |
|
|
2015
Q2 | $3.32M | Buy |
+17,702
| New | +$3.05M | 0.01% | 1210 |
|
|
2014
Q2 | – | Sell |
-769
| Closed | -$140K | – | 2178 |
|
|
2014
Q1 | $140K | Buy |
769
+59
| +8% | +$11.7K | ﹤0.01% | 2197 |
|
|
2013
Q4 | $121K | Sell |
710
-2
| -0.3% | -$323 | ﹤0.01% | 2182 |
|
|
2013
Q3 | $112K | Hold |
712
| – | – | ﹤0.01% | 2499 |
|
|
2013
Q2 | $123K | Buy |
+712
| New | +$109K | ﹤0.01% | 2182 |
|
Other funds holding NKTR
Comerica Bank's NKTR Position: Q4 2022 in Review
Comerica Bank reduced its Nektar Therapeutics (NKTR) stake by 22% in Q4 2022, selling an estimated $100K and leaving 7,369 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #1984.
Comerica Bank first reported a position in NKTR in Q2 2013 and has held it in 35 quarters since. The position peaked at $12.4M in Q4 2017. 214 funds tracked by Wall St. Rank hold NKTR as of Q4 2022.
- Comerica Bank held 7,369 shares of Nektar Therapeutics worth $275K as of Q4 2022.
- Comerica Bank sold 2,068 Nektar Therapeutics shares in Q4 2022, an estimated $100K.
- Nektar Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2022, its #1984 holding.
- Comerica Bank first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 35 quarters since.
- Comerica Bank's Nektar Therapeutics position peaked at $12.4M in Q4 2017.
- 214 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2022.
Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.